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Xeroderma pigmentosum variant (XPV) cells are characterized by a cellular defect in the ability to synthe-
size intact daughter DNA strands on damaged templates. Molecular mechanisms that facilitate replication
fork progression on damaged DNA in normal cells are not well defined. In this study, we used single-stranded
plasmid molecules containing a single N-2-acetylaminofluorene (AAF) adduct to analyze translesion synthesis
(TLS) catalyzed by extracts of either normal or XPV primary skin fibroblasts. In one of the substrates, the
single AAF adduct was located at the 3* end of a run of three guanines that was previously shown to induce
deletion of one G by a slippage mechanism. Primer extension reactions performed by normal cellular extracts
from four different individuals produced the same distinct pattern of TLS, with over 80% of the products
resulting from the elongation of a slipped intermediate and the remaining 20% resulting from a nonslipped
intermediate. In contrast, with cellular extracts from five different XPV patients, the TLS reaction was strongly
reduced, yielding only low amounts of TLS via the nonslipped intermediate. With our second substrate, in
which the AAF adduct was located at the first G in the run, thus preventing slippage from occurring, we
confirmed that normal extracts were able to perform TLS 10-fold more efficiently than XPV extracts. These
data demonstrate unequivocally that the defect in XPV cells resides in translesion synthesis independently of
the slippage process.
Xeroderma pigmentosum (XP) is an autosomal recessive
disorder characterized by a genetic predisposition to sunlight-
induced skin cancer. Fibroblasts derived from patients with XP
are extremely sensitive to the mutagenic effect of UV irradia-
tion (19). The majority of XP patients are deficient in nucle-
otide excision repair, and there have been dramatic advances
in our understanding of the molecular defects in these patients.
In contrast, there has been little progress in our understanding
of the molecular defect in the XP variant (XPV) group, which
comprises a substantial minority (approximately 20%) of XP
patients. They have normal levels of nucleotide excision repair
and normal sensitivity to the lethal effects of UV irradiation (5)
but a marked defect in the ability to synthesize intact daughter
DNA strands during DNA replication after some (4, 17, 20, 26)
but not all (4, 7) types of carcinogenic damage. The cellular
defect in DNA replication in UV-irradiated XPV cells was
discovered as long ago as 1975 (17), but because of the normal
sensitivity to killing by UV light, the XPV gene has been
refractory to cloning. The precise nature of the molecular
defect in this important class of XP patients remains one of the
major unsolved problems in this area.
The UV hypermutability of XPV cells could be due to an
abnormal error-prone mechanism of replication. This hypoth-
esis is supported by results showing that mutation spectra in
UV-irradiated XPV cells are distinct from those observed in
normal cells (32, 33). In XPV cells, the UV-induced substitu-
tions are mainly transversions (C3A), whereas in normal cells,
transitions (C3T) predominate. An altered mutation pattern
was also generated by psoralen photoadducts in XPV com-
pared to normal cells (27). To determine whether the process
of translesion synthesis (TLS) in XPV extracts differs from that
of normal cells, we compared the abilities of cellular extracts
from either normal or XPV primary fibroblasts to perform
primer elongation past a unique blocking lesion located on a
single-stranded circular template. This approach allows TLS to
be investigated both quantitatively and qualitatively in the ab-
sence of other cellular responses such as repair, recombina-
tion, or polymerase strand switching. This assay will greatly
facilitate the identification of the XPV gene product(s) and the
biochemical features of replication of damaged DNA in hu-
man cells.
MATERIALS AND METHODS
Construction of single-stranded plasmid containing a single AAF adduct. The
strategy used to construct double-stranded molecules containing single N-2-
acetylaminofluorene (AAF) adducts involved the formation of gapped-duplex
molecules (14). A 14-mer oligonucleotide d(ATACCCG1G2G3ACATC) was
reacted with N-acetoxy-N-2-acetylaminofluorene under conditions such as to
create one adduct per oligonucleotide on average. The crude reaction mixture
was subjected to reverse-phase high-pressure liquid chromatography, and the
oligonucleotides with a single AAF adduct at G1 or G3 were purified and ligated
into the gap to generate plasmid pUC-3G1 or pUC-3G3, respectively. A control
undamaged plasmid, pUC-3G0, was constructed with the unreacted control
oligonucleotide. The single-stranded vectors (pUC-3G0.ss, pUC-3G1.ss, and
pUC-3G3.ss) were produced from the corresponding double-stranded plasmids
by selective enzymatic degradation of the nonadducted uracil-containing strand.
A detailed description of this procedure using an enzymatic cocktail containing
uracil-DNA glycosylase, exonuclease III, and the 39359 exonuclease activity
associated with T7 DNA polymerase has been described recently (23).
Cell cultures. The cell strains used in this study were fibroblast cultures
derived from the skin of normal individuals (1BR3, 205BR, 250BR, and 368BR)
and XP variants (XP7BR, XP11BR, XP6DU, XP7DU, and XP30R0). The XP
variants were all defective in postreplication repair of UV damage as shown by
sucrose density gradient analysis of newly synthesized DNA in UV-irradiated
cells (reference 17 [XP30R0] and our unpublished results [other cell strains]).
XP11BR cells are derived from the patient described in reference 3. All cell
strains were grown in Dulbecco’s modified Eagle’s medium (Sigma) supple-
mented with 15% fetal calf serum (Eurobio) and 50 mg of gentamicin (Sigma)
per ml.
Preparation of cell extracts. Cell extracts (100 ml) were obtained from 107
exponentially growing cells essentially as described previously (13). The cells
were washed twice with phosphate-buffered saline (PBS). trypsin (0.25% in PBS)
was added to the plates, which were then incubated at 37°C until cells rounded
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up and were almost ready to detach. Excess buffer was removed, and the cells
were collected by agitation in the culture medium. The cells were pelleted by
centrifugation (1,000 3 g for 5 min) and washed once in the culture medium and
twice in PBS. The cell pellet was resuspended in 4 volumes of ice-cold hypotonic
buffer (10 mM Tris-HCl [pH 7.5], 10 mM KCl, 10 mM MgCl2, 1 mM dithiothre-
itol [DTT]) containing protease inhibitors (1 mM phenylmethylsulfonyl fluoride
and 5 mg each of leupeptin, chymostatin, and aprotinin per ml). The cells were
allowed to swell on ice for 30 min at 4°C and disrupted with 20 strokes of a
tight-fitting pestle in a Dounce homogenizer. Cell disruption and integrity of the
nuclei were examined under light microscopy by exclusion of trypan blue. Nuclei
were harvested by centrifugation for 10 min at 3,000 3 g at 4°C, and cytosolic
supernatants were kept on ice. After 1 h of extraction at 0°C in hypotonic buffer
containing 350 mM NaCl, the nuclear extracts were centrifuged at 10,000 3 g for
10 min. Cytosolic and nuclear extracts were mixed, and the proteins were pre-
cipitated by the addition of ammonium sulfate (0.33 g/ml) and gentle stirring for
1 h at 4°C. The precipitates were collected by centrifugation (45 min at 10,000 3
g), resuspended in dialysis buffer (100 mM potassium glutamate, 30 mM HEPES
[pH 7.5], 1 mM DTT, 10% glycerol), and dialyzed for 2 h at 4°C. The extracts
were clarified by centrifugation for 10 min at 10,000 3 g and stored at 280°C.
The protein concentration of extracts is typically between 5 and 15 mg/ml as
measured by the Bradford protein assay (Bio-Rad) using bovine serum albumin
as the standard.
In vitro primer extension assays. A primer (24-mer oligonucleotide) was
phosphorylated with T4 polynucleotide kinase (New England Biolabs), using 50
pmol of [g-32P]ATP (3,000 Ci/mmol; Amersham). After purification by electro-
phoresis on a 20% polyacrylamide–7 M urea denaturing gel, the primer (twofold
molar excess) was annealed to single-stranded DNA in a buffer containing 60
mM HEPES (pH 7.5) and 20 mM MgCl2. The mixture was incubated at 50°C for
15 min with Escherichia coli SSB (Pharmacia). For primer extension assays, the
reaction mixture (6.25 ml) containing 10 fmol of SSB-coated primed DNA, and
whole-cell extract was incubated at 37°C in 50 mM HEPES-KOH (pH 7.8)–7 mM
MgCl2–1 mM DTT–4 mM ATP–500 mM deoxynucleoside triphosphates
(dNTPs)–200 mM each UTP, CTP, and GTP–40 mM creatine phosphate–100 mg
of creatine kinase per ml. The reaction was stopped by adding an equal volume
of proteinase K (4 mg/ml)-sodium dodecyl sulfate (2%) and incubated for 30 min
at 37°C. The samples were precipitated in the presence of 1 M ammonium
acetate and 50% isopropanol. Replication products were digested with restric-
tion enzymes EcoRI, PvuII, and SmaI in buffers recommended by the manufac-
turers and analyzed by electrophoresis on a polyacrylamide–7 M urea denaturing
gel.
RESULTS
Design of the damaged single-stranded DNA substrate. We
used AAF as a model DNA-damaging agent to analyze the
ability of cell extracts to carry out TLS. AAF adducts at the C8
position of guanine (dGua-C8-AAF) are severe blocks to in
vitro DNA synthesis by purified prokaryotic and eukaryotic
DNA polymerases (2, 21, 22). TLS past AAF adducts in both
double-stranded (30, 31) and forked single-stranded (13) DNA
templates has been observed to some extent in cell extracts.
This suggests that extracts accurately mimic at least some of
the mechanisms that rescue a blocked replication fork in vivo.
In the present study, single-stranded plasmids containing single
AAF adducts at G1 or G3 in a run of three guanines (59-
G1G2G3-39) were constructed to analyze TLS. In E. coli, when
located at G3 in the run (59-GGGAAF-39), an AAF adduct
induces 21 frameshift mutations at least 100-fold more effi-
ciently than when located at G1 (59-GAAFGG-39) (15). Indeed,
a G3 adduct can trigger a primer-template misalignment event
yielding a slipped intermediate that is in equilibrium with its
nonslipped counterpart, while such an event is not favored for
a G1 adduct (Fig. 1A). Cellular extracts from either normal or
XPV primary fibroblasts were tested for their abilities to elon-
gate a 32P-end-labeled oligonucleotide (24-mer) annealed to
the single-stranded circular template, at a distance of 91 (pUC-
3G3.ss) or 93 (pUC-3G1.ss) nucleotides from the lesion site.
TLS was analyzed on sequencing gels following PvuII and
EcoRI restriction digestion of the DNA products (Fig. 1B).
For both substrates, TLS resulting from the elongation of non-
slipped (TLS0) and slipped (TLS21 [21 frameshift event])
intermediates will yield fragments with lengths of 104 and 103
nucleotides, respectively.
Primer extension using the unmodified substrate. The rep-
lication activities of extracts from normal (205BR) and XPV
(XP6DU) cells were tested by using a primed unmodified sin-
gle-stranded template (pUC-3G0.ss). For both extracts, prod-
uct yield increased with increasing amounts of protein (Fig.
2A). In a typical time course experiment, radiolabeled 104-
nucleotide products were detected after a 2-min reaction and
reached a plateau at 10 min. Completion of DNA synthesis
around the whole template followed by subsequent ligation
was observed by the appearance of a band at 119 nucleotides
(Fig. 2B). Quantitative analysis of the results indicates that
after a 1-h incubation with 48 mg of either extract, about 20%
of the primers were elongated. All of these data indicate that
XPV cell extracts have replication activity similar to that of
normal cells on a lesion-free template, consistent with the
normal DNA replication observed in undamaged XPV cells in
vivo (17).
Differential TLS catalyzed by extracts from normal or XPV
extracts. TLS can be described in terms of the different repli-
cation intermediates that are involved. The replication inter-
mediate in which the last nucleotide of the primer is located
opposite the lesion in the template will be referred to as a
lesion terminus (LT). All replication intermediates preceding
and succeeding this step will be referred to as prelesion termini
(pre-LT) and postlesion termini (post-LT), respectively. Given
these definitions, TLS can be viewed as a succession of at least
two reactions (pre-LT3LT3post-LT). The progression from
one step to the next normally requires a DNA synthesis step. A
marked difference between normal and XPV extracts was ob-
served for TLS past the AAF adduct at the G3 position (Fig.
3A). Despite the presence of the lesion on the modified sub-
strate (pUC-3G.3ss), normal extracts (205BR) were able to
catalyze TLS efficiently as 40 to 60% of the elongated primers
were extended past the adduct site upon incubation with 48 mg
of normal extract proteins. Both nonslipped (TLS0) and
slipped (TLS21) elongation products were seen (Fig. 3A,
FIG. 1. AAF-induced 21 frameshift pathway. The primer terminus when
located opposite the lesion site is designated the lesion terminus (LT). The LT
can isomerize via a slippage mechanism into the slipped intermediate, which has
a paired primer terminus (post-LT). Elongation from the nonslipped and slipped
intermediates lead to TLS0 and TLS21 products, respectively. (B) Diagram of
the modified template, pUC-3G3.ss. A single AAF adduct is located with the
recognition site of SmaI. The positions of PvuII and EcoRI restriction sites and
lengths of the strands produced upon elongation of the labeled primer are
indicated. L0, fragment elongated up the lesion site; nt, nucleotides.
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lanes 1 to 4), the latter constituting over 80% of the TLS
products formed. This finding indicates that the replication
complex is able to elongate the slipped LT more efficiently
than the corresponding nonslipped intermediate. The slipped
intermediate exhibits a normal G z C base pair at its terminus
and therefore mimics a post-LT (Fig. 1A). A distinct feature of
the slipped TLS reaction is that the formation of the slipped
intermediate occurs by isomerization of the LT in the absence
of a DNA synthesis step. As a consequence, the slipped TLS
reaction is unique in the sense that the otherwise critical step
converting the LT to a post-LT occurs in the absence of DNA
synthesis. With normal cell extracts, a distinct pattern of bands
is also observed near the adduct site, as elongation products
blocked both one nucleotide before the lesion site (L21) and
opposite the lesion (L0) are seen.
In marked contrast, comparable reactions with an XPV ex-
tract (lanes 5 to 8) resulted in the accumulation of replication
products blocked one nucleotide before the lesion (position
L21) and of low amounts of nonslipped elongation product
(TLS0). The slipped elongation product (TLS21) was barely
detectable. Therefore, bands L0 and TLS21 appear to be
diagnostic for normal cells (which we will refer to as the nor-
mal cell TLS pattern), as they are absent in all five XPV
extracts tested (Fig. 3A and 4). It should be stressed that
failure of XP variants to effect TLS via the slipped intermedi-
ate was obtained even under the forcing conditions used, such
as long incubation periods (1 h) and high dNTP concentrations
(500 mM dNTPs). These conditions increased the overall effi-
ciency of TLS in normal extracts but did not modify the relative
ratio of TLS0 to TLS21 (data not shown). In addition, neither
the passage number of the cells nor the position of the primer
with respect to the lesion site altered the reaction (data not
shown). Our results were confirmed in a blind study in which
coded samples of two normal and two XPV cell strains, pro-
vided by A. R. Lehmann, were correctly identified.
It was important to confirm that the TLS products actually
resulted from synthesis past the AAF lesion, rather than on
contaminating undamaged substrate. The AAF lesion is situ-
ated in a sequence of DNA which, in the absence of the lesion,
is a substrate for cleavage by the restriction enzyme SmaI. To
provide direct evidence that DNA synthesis had actually oc-
curred past the lesion, we tested the resistance of the TLS0
product DNA to cleavage by SmaI. With pUC-3G0.ss, incision
at the recognition site converted the labeled major fragment of
104 nucleotides and minor fragment of 119 nucleotides (Fig.
1B) to smaller bands of 93 and 108 nucleotides, respectively
(Fig. 3B). In contrast, TLS0 elongation products obtained with
damaged template were resistant to cleavage, indicating that
the adduct was indeed present in the double-stranded DNA
obtained after replication in vitro (Fig. 3B).
Increasing amounts of normal extract stimulated TLS (Fig.
3A, lanes 1 to 4). Generally, optimal activity was obtained with
30 to 50 mg of protein per 10 ng of DNA, and at a higher
protein concentration, TLS declined (data not shown). Addi-
tion of XPV extracts to limiting amounts of normal extracts (8
and 16 mg) did not inhibit TLS; on the contrary, increasing
amounts of products at position L0 and TLS21 were detect-
able when the two extracts were combined (Fig. 3A, lanes 9 to
12). This observation demonstrating the absence of a dominant
negative factor in XPV extracts is consistent with the recessive
mode of transmission of the XPV defect. The addition of 32 mg
FIG. 2. DNA synthesis catalyzed by normal (N: 205BR) or XPV (XPV:
XP6DU) extracts, using the unmodified single-stranded template (pUC-3G0.ss).
(A) Titration of DNA synthesis activity after 1 h of incubation. (B) Time course
of DNA synthesis catalyzed by 48 mg of normal and XPV proteins. DNA prod-
ucts obtained after 1 h of incubation with pUC-3G0.ss were cleaved with enzymes
PvuII and EcoRI and subjected to electrophoresis on an 8% polyacrylamide–7 M
urea denaturing gel. nt, nucleotides.
FIG. 3. TLS by extracts from normal or XPV cells, using the pUC-3G3.ss
substrate. (A) Analysis of TLS catalyzed by various amounts of either normal (N:
205BR; lanes 1 to 4) or XPV (XPV: XP6DU; lanes 5 to 8) cell extracts. In lanes
9 to 12, different amounts of normal and XPV extracts were mixed. Asterisks
indicate that the proteins were heated at 50°C for 10 min before the assay. DNA
products obtained after 1 h of incubation with pUC-3G3.ss were cleaved with
enzymes PvuII and EcoRI and subjected to electrophoresis on an 8% polyacryl-
amide–7 M urea denaturing gel. L21 and L0 are products generated if synthesis
is blocked one nucleotide before and opposite the lesion, respectively. TLS0 and
TLS21 are products from TLS via nonslipped and slipped intermediates. Over-
exposure (fivefold) of the portion of the gel indicated by dashes is shown at the
top. (B) Resistance to SmaI digestion of TLS0 products generated by 30 mg of
normal (1BR3 and 205BR) cell extracts. DNA products obtained after 1 h of
incubation with pUC-3G0.ss or pUC-3G3.ss were cleaved with enzymes PvuII
and EcoRI. Half of the DNA samples were further digested by SmaI as indicated
and subjected to electrophoresis on an 8% polyacrylamide–7 M urea denaturing
gel. nt, nucleotides.
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of XPV extract to a limiting amount (16 mg) of normal cell
extract stimulates the normal cell TLS pattern (i.e., presence of
bands TLS-1 and L0) compared to the replication assay where
the same quantity of heat-inactivated XPV extract is added to
limiting quantities of normal cell extract (Fig. 3A, lanes 9 and
10). This finding demonstrates that it is not the XPV factor
that limits the TLS reaction with 16 mg of normal cell extracts
since XPV extracts can stimulate the normal cell TLS pattern
under these conditions. On the other hand, heat inactivation of
the normal cell extract (lane 11) yields the TLS pattern typical
for XPV cells (i.e., absence of both TLS21 and L0 bands).
Complementation studies. The assay described above pro-
vides a complementation approach to isolate proteins from
normal extracts that would allow XPV extracts to produce
TLS21 efficiently with pUC-3G3.ss as a template. As a first
step, we tested complementation between extracts from five
different XPV individuals (Fig. 4). Complementation was not
observed upon mixing equal amounts of any of the five ex-
tracts, suggesting that these five XPV patients are mutated in
the same gene.
Analysis of TLS by using a substrate where the possibility of
slippage is reduced. The data obtained with the pUC-3G3.ss
substrate indicate that XPV extracts are less able than normal
extracts to elongate a primer past an AAF adduct. However,
this defect could be specific for the elongation of the post-LT
generated by slippage (Fig. 1). Another possibility could be
that a misincorporation at this site prevents slippage from
occurring. To further investigate these points, we analyzed
TLS by using a substrate where the slippage process is mini-
mized because the AAF adduct is located on the first G of the
run (pUC-3G1.ss). We previously showed (15) that at this
position, the frequency of induced 21 frameshift mutation was
reduced 100-fold in vivo in E. coli. Interestingly, cellular ex-
tracts from normal cells were able to perform TLS with pUC-
3G1.ss as efficiently as with pUC-3G3.ss (Fig. 5). In agreement
with the result obtained with E. coli, TLS using substrate pUC-
3G1.ss resulted mainly in normal elongation products (TLS0).
The TLS21 products could consist of either targeted deletions
(-G within the run of guanine residues) or semitargeted dele-
tions (-C in the 59 flanking repetitive cytosine sequence) as
found in E. coli (15). In the vicinity of the lesion site, the
presence of three bands at L21, L0, and L11 revealed that the
adduct hindered the progression of DNA synthesis. Obviously,
the absence of band L11 when pUC-3G3.ss was used as the
template indicates that this step was obviated by the slippage
event. Irrespective of the site of the lesion (G1 or G3), the
efficiency of TLS was highly reduced with XPV extracts.
The high amount of TLS0 obtained in normal extracts with
the pUC-3G1.ss substrate indicates that efficient TLS can oc-
cur independently of the slippage process. In XPV extracts, the
efficiency of TLS was reduced 10-fold, providing evidence that
the nonslipped TLS product formed with normal cell extracts
upon incubation with pUC-3G1.ss arises by a mechanism that
required the XPV factor, similarly to the slipped TLS product
formed with pUC-3G3.ss.
DISCUSSION
Complete replication past site-specific UV-induced lesions
(6, 29) or AAF adducts (30, 31) in double-stranded DNA
carrying the simian virus 40 origin of replication has been
observed in HeLa cell extracts, in the presence of T antigen.
Recently, using a similar approach, three groups (8, 9, 28)
demonstrated that in contrast to normal cell extracts, extracts
from XPV cells were completely (8) or partially (9, 28) defi-
cient in the bypass of a single cis-syn thymine dimer. In these
studies, impaired replication fork bypass observed in XPV
extracts could be due to a defect either in mechanisms broadly
referred to as postreplication repair (such as polymerase tem-
plate switching or recombinational strand transfer) or in a
simple TLS reaction. However, in the present work, using a
single-stranded template with a single lesion, we show directly
and unequivocally that it is TLS that is impaired in XPV
extracts. This result highlights the biological importance of a
factor(s) involved in TLS in human cells, since a defect in this
pathway leads to enhanced mutagenesis and to sunlight-in-
duced skin cancer.
TLS in normal cell extracts. In normal cell extracts, the slow
process of formation of complete TLS products past the AAF
FIG. 4. Absence of complementation between extracts from five different
XPV individuals. XPV extracts (15 mg of each) were mixed together as indicated
and incubated for 1 h with pUC-3G3.ss. In parallel, 30 mg of normal (N; 205BR)
or XPV extracts was incubated with pUC-3G3.ss. DNA products were cleaved
with enzymes PvuII and EcoRI and subjected to electrophoresis on an 8%
polyacrylamide–7 M urea denaturing gel. Overexposure (13-fold) of the portion
of the gel indicated by dashes is shown at the top. XPV extracts: 1, XP11BR; 2,
XP30R0; 3, XP7BR; 4, XP6DU; 5, XP7DU. All of these cell strains have the
cellular defect in DNA synthesis after UV irradiation (unpublished data and
reference 17) that is diagnostic for XP variants.
FIG. 5. TLS past and AAF adduct by extracts from normal or XPV cells.
Analysis of TLS catalyzed by 30 mg of either normal (N; 205BR) or XPV
(XP6DU) cell extracts. DNA products obtained after 1 h of incubation with
pUC-3G1.ss or pUC-3G3.ss were cleaved with enzymes PvuII and EcoRI and
subjected to electrophoresis on an 10% polyacrylamide–7 M urea denaturing gel.
L21, L0, and L11 are products generated if synthesis is blocked one nucleotide
before, opposite, and one nucleotide after the lesion, respectively. TLS0 and
TLS21 are products from TLS via nonslipped and slipped intermediates. As an
internal standard, an identical amount of a 120-nucleotide fragment (end labeled
with [g-32P]ATP by T4 polynucleotide kinase) was added to each reaction at the
end of the replication step.
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adduct and the pattern of bands seen in the vicinity of the
adduct site show that the replication apparatus stalls at the
lesion. This finding suggests that the conformational change
induced by AAF adducts in the template DNA (rotation of the
guanine moiety from the anti to the syn conformation [for a
review, see reference 12]) hinders this replication step. It is
thought that modification of the replication multiprotein ap-
paratus (such as ubiquitination by the Rad6-Rad18 het-
erodimer in yeast), release and/or recruitment of accessory
proteins, and replacement of the DNA polymerase are neces-
sary to overcome the block in vivo (16). Interestingly, in Sac-
charomyces cerevisiae, TLS past an AAF adduct in the three-G
sequence context requires the Rev3 (1) and to a large extent
the Rev1 protein (1a). Rev3p together with Rev7p forms a
heterodimeric DNA polymerase designated Polz, dedicated to
replication on damaged DNA (25). Rev1p has weak homology
with the E. coli UmuC protein and has a deoxycytidyltrans-
ferase activity (24). Human homologs of Rev1 and Rev3
(hsREV3) have been identified (10, 16). In view of the involve-
ment of these proteins in TLS past AAF adducts in yeast, it is
tempting to speculate that they may also participate in TLS
past AAF adducts in our assay. This raises the possibility that
homologs of the Rev1, Rev3, and Rev7 protein are products of
the XPV gene(s). In a study to be presented in detail else-
where, using sequence and segregation analysis, we have been
able to exclude the hsREV3 as the gene defective in XPV
patients (4a). Recent work demonstrated that the great major-
ity of UV-induced mutations were abolished in cultured hu-
man cells expressing an hsREV3 antisense RNA fragment
(10), supporting a mechanism of Polz-dependent translesion
replication of UV photoproducts in human cells. However,
since UV-irradiated XPV cells are hypermutable, the XPV
defect cannot be explained simply by an abrogation of TLS via
Polz, but rather involves subtle alteration of this specific path-
way leading to enhanced UV-induced mutagenesis. On the
other hand, Pold (11) was also shown to be involved in UV-
induced mutagenesis in yeast. Thus, the XPV factor could be a
component of the normal replication machinery.
TLS in XPV extracts. TLS must overcome two problems:
first the insertion of a nucleotide opposite the residue contain-
ing the adduct (insertion) and second, following insertion, ex-
tension of the improperly base-paired terminus (elongation).
From the present work, it appears that the primary defect in
XPV extracts residues in their reduced ability to incorporate
(or stably maintain) a nucleotide in front of the AAF adduct
(absence of band L0). This defect observed in vitro reflects the
in vivo situation, in which replication blocks occur at the sites
of damage in UV-irradiated XPV cells (4, 17, 26).
The qualitative difference between the TLS patterns pro-
duced in normal extracts and in XPV extracts suggests that
different pathways of TLS coexist in mammalian cells. In the
absence of a functional XPV factor, an alternative, minor TLS
pathway yields the small amount of products specific for XPV
extracts (i.e., relatively high amount of TLS21 with pUC-
3G1.ss and absence of TLS21 with pUC-3G3.ss). The en-
hancement by caffeine of the defect in replication on damaged
templates in XPV cells (17, 18) as well as the distinct UV- and
psoralen-induced mutation spectrum observed in these cells
compared to normal cells (27, 32, 33) might be hallmarks of
this residual TLS pathway. Hypermutability of XPV cells after
UV irradiation can thus be explained by the use of this specific
pathway of TLS, less efficient but more error prone than the
major pathway observed in normal extracts. To confirm this
hypothesis and to get a better understanding of XPV patho-
genesis, we are currently extending our analysis to several
different photoproducts.
The assay described in this paper provides a unique oppor-
tunity to distinguish different pathways of TLS in eukaryotic
cell extracts. It provides compelling evidence that XPV cells
are defective in a major TLS pathway. This assay should greatly
facilitate attempts to clone the XPV gene and to identify pro-
teins involved in bypass of lesions in eukaryotes.
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